Evidence map›Paper›PMID 36801707›Full record

ArticleDrug and alcohol dependence2023

Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis.

Ofer Amram, Leah Rosenkrantz, Solmaz Amiri DDes, Nadine Schuurman, Victoria J Panwala, Paul J Joudrey

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ofer AmramElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA; Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA 99164, USA. Electronic address: ofer.amram@wsu.edu.
Leah RosenkrantzDepartment of Geography, Simon Fraser University, British Columbia, Canada.
Solmaz Amiri DDesElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.
Nadine SchuurmanDepartment of Geography, Simon Fraser University, British Columbia, Canada.
Victoria J PanwalaElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.
Paul J JoudreyDivision of General Internal Medicine, University of Pittsburgh School of Medicine, USA.

Funding

NIDA NIH HHS L30 DA052056
6 · The paper itself

Abstract

objectivesWe sought to compare timely access to methadone treatment in the United States (US) and Canada during the COVID-19 pandemic.

methodsWe conducted a cross-sectional study of census tracts and aggregated dissemination areas (used for rural Canada) within 14 US and 3 Canadian jurisdictions in 2020. We excluded census tracts or areas with a population density of less than one person per square km. Data from a 2020 audit of timely medication access was used to determine clinics accepting new patients within 48 h. Unadjusted and adjusted linear regressions were performed to examine the relationship between area population density and sociodemographic covariates and three outcome variables: 1) driving distance to the nearest methadone clinic accepting new patients, 2) driving distance to the nearest methadone clinic accepting new patients for medication initiation within 48 h, and 3) the difference in the driving distance between the first and second outcome.

resultsWe included 17,611 census tracts and areas with a population density greater than one person per square kilometer. After adjusting for area covariates, US jurisdictions were a median of 11.6 miles (p value <0.001) further from a methadone clinic accepting new patients and 25.1 miles (p value <0.001) further from a clinic accepting new patients within 48 h than Canadian jurisdictions.

conclusionsThese results suggest that the more flexible Canadian regulatory approach to methadone treatment is associated with a greater availability of timely methadone treatment and reduced urban-rural disparity in availability, compared to the US.

Indexed as

COVID-19PandemicsCanadaCross-Sectional StudiesHumansMethadoneUnited StatesMethadoneAccessCOVID-19MethadoneOATTreatment initiation

Identifiers

PMID36801707
PMCPMC9908565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.